Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD  Single & Dual Chamber  CRT-D  S-ICD) and External (Manual  AED  Wearable))  End User (Hospitals  Prehospital  Public Access  Home care) - Global Forecast to 2022

Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD Single & Dual Chamber CRT-D S-ICD) and External (Manual AED Wearable)) End User (Hospitals Prehospital Public Access Home care) - Global Forecast to 2022

MarketsandMarkets | ID: 1524152631338 | Published at: 2018-02-19 | Pages: 171

  • €4.785,63


“The global defibrillators market projected to grow at a CAGR of 3.1%.”
The global defibrillators market is expected to reach USD 10.88 billion by 2022 from USD 9.32 billion in 2017, growing at a CAGR of 3.1%. Factors such as technological advancements in defibrillators, rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training & awareness programs on defibrillators are expected to propel the growth of this market. However, issues related to the use of implantable and automated external defibrillators are expected to restrain the growth of the defibrillators market in the forecast period. The defibrillators market has witnessed significant developments in terms of technological advancements and new product developments. The external defibrillators available in the market have provided numerous benefits to patients in terms of ease-of-use, increased patient comfort, and increased accessibility.

“The external defibrillators segment is expected to grow at the highest CAGR during 2017 to 2022.”
On the basis of products, the defibrillators market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs product segment is bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). The T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds). The external defibrillators segment is further classified into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs). The external defibrillators segment is expected to grow at the highest CAGR in the forecast period, owing to factors such as the growing focus of key market players on developing easy-to-use defibrillators, increasing support from governments to install AEDs at public places, and rising adoption of WCDs.

“The hospitals, clinics, and cardiac centers segment to dominate the global defibrillators market during the forecast period.”
On the basis of end user, the defibrillators market is segmented into hospitals, clinics, and cardiac centers; pre-hospital care settings; public access markets; alternate care facilities; and home care settings. The hospitals, clinics, and cardiac centers segment is estimated to account for the largest share of the defibrillators market in 2017. Growing number of cardiac implant procedures across the globe and the availability of reimbursements across the developed markets are some of the major factors driving the growth of this segment.

“APAC is projected to witness the highest growth during the forecast period.”
The Asia Pacific defibrillators market is expected to grow at the highest CAGR of from 2017 to 2022. Factors such as the rapidly growing aging population, increasing cases of cardiovascular diseases, improving research infrastructure, and growing focus of key market players to expand their presence in this region are driving the growth of the Asia Pacific defibrillators market.

Breakdown of supply-side primary interviews: by company type, designation, and region:
• By Company Type – Tier 1 –31%, Tier 2 –48% and Tier 3 –21%
• By Designation – C-level – 26%, Director-level – 24%, Others – 50%
• By Region – North America – 29%, Europe – 35%, APAC – 21%, RoW – 15%

The key players in the defibrillators market include Medtronic (Ireland), St. Jude Medical (US), Boston Scientific (US), Koninklijke Philips N.V. (Netherlands), ZOLL Medical (US), BIOTRONIK (Germany), Physio-Control (US), Cardiac Science (US), LivaNova (UK), Nihon Kohden (Japan), SCHILLER (Switzerland), Mindray Medical (China), Mediana (South Korea), METRAX (Germany), and METsis (Turkey).

Research Coverage
This report studies the defibrillators market based on product, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on business strategies adopted by the major players in the defibrillators market. The report analyzes the defibrillators market based on product, end user, and region

• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the defibrillators market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various defibrillators across geographies

• Market Diversification: Exhaustive information about new defibrillator products, untapped geographies, recent developments, and investments in the defibrillators market

• Competitive Assessment: In-depth assessment of market ranking, strategies, and products of leading players in the defibrillators market

TABLE OF CONTENTS

1 INTRODUCTION 15

  • 1.1 OBJECTIVES OF THE STUDY 15
  • 1.2 DEFINITION 15
  • 1.3 MARKET SCOPE 16
  • 1.4 YEARS CONSIDERED FOR THE STUDY 17
  • 1.5 CURRENCY 17
  • 1.6 LIMITATIONS 17
  • 1.7 STAKEHOLDERS 18
    2 RESEARCH METHODOLOGY 19
  • 2.1 RESEARCH DATA 19
    • 2.1.1 SECONDARY DATA 20
      • 2.1.1.1 Secondary sources 20
    • 2.1.2 PRIMARY DATA 21
      • 2.1.2.1 Breakdown of primaries 21
      • 2.1.2.2 Primary sources 22
  • 2.2 MARKET SIZE ESTIMATION 22
    • 2.2.1 BOTTOM-UP APPROACH 23
    • 2.2.2 TOP-DOWN APPROACH 24
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25
  • 2.4 ASSUMPTIONS 26
    3 EXECUTIVE SUMMARY 27
    4 PREMIUM INSIGHTS 31
  • 4.1 DEFIBRILLATORS: MARKET OVERVIEW 31
  • 4.2 REGIONAL ANALYSIS: DEFIBRILLATORS MARKET, BY PRODUCT 32
  • 4.3 DEFIBRILLATORS MARKET, BY END USER 33
  • 4.4 GEOGRAPHICAL SNAPSHOT OF THE DEFIBRILLATORS MARKET 33
    5 MARKET OVERVIEW 34
  • 5.1 INTRODUCTION 34
  • 5.2 MARKET DYNAMICS 34
    • 5.2.1 DRIVERS 35
      • 5.2.1.1 Technological advancements in defibrillators 35
      • 5.2.1.2 Rising prevalence of target diseases 35
      • 5.2.1.3 Growing focus on providing public-access defibrillators 37
      • 5.2.1.4 Training & awareness programs on defibrillators 37
    • 5.2.2 RESTRAINTS 38
      • 5.2.2.1 Issues related to the use of implantable and automated external defibrillators 38
    • 5.2.3 OPPORTUNITIES 38
      • 5.2.3.1 Emerging markets offer significant growth opportunities 38
      • 5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds 39
    • 5.2.4 CHALLENGES 40
      • 5.2.4.1 Frequent product recalls 40
      • 5.2.4.2 Lack of awareness about sudden cardiac arrest in developing nations 42
  • 5.3 INDUSTRY TRENDS 42
    • 5.3.1 INCREASING PRICING PRESSURE ON MARKET PLAYERS 42
    • 5.3.2 GROWING NUMBER OF MERGERS AND ACQUISITIONS AMONG MARKET PLAYERS 43
    • 5.3.3 RISING DEMAND FOR AUTOMATED EXTERNAL DEFIBRILLATORS IN PREHOSPITAL SETTINGS 43
  • 5.4 REGULATORY SCENARIO 44
    • 5.4.1 EXTERNAL DEFIBRILLATORS 44
    • 5.4.2 IMPLANTABLE DEFIBRILLATORS 44
      6 GLOBAL DEFIBRILLATORS MARKET, BY PRODUCT 46
  • 6.1 INTRODUCTION 47
  • 6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 48
    • 6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 52
      • 6.2.1.1 Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators 53
      • 6.2.1.2 Dual-chamber ICDs 54
      • 6.2.1.3 Single-chamber ICDs 55
    • 6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 56
  • 6.3 EXTERNAL DEFIBRILLATORS 57
    • 6.3.1 AUTOMATED EXTERNAL DEFIBRILLATORS 60
      • 6.3.1.1 Semi-automated External Defibrillators 61
      • 6.3.1.2 Fully automated external defibrillators 62
    • 6.3.2 MANUAL EXTERNAL DEFIBRILLATORS 63
    • 6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS 64
      7 DEFIBRILLATORS MARKET, BY END USER 66
  • 7.1 INTRODUCTION 67
  • 7.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS 67
  • 7.3 PRE-HOSPITAL CARE SETTINGS 68
  • 7.4 PUBLIC ACCESS MARKETS 70
  • 7.5 HOME CARE SETTINGS 71
  • 7.6 ALTERNATE CARE FACILITIES 72

8 DEFIBRILLATORS MARKET, BY REGION 74

  • 8.1 INTRODUCTION 75
  • 8.2 NORTH AMERICA 78
    • 8.2.1 US 82
    • 8.2.2 CANADA 84
  • 8.3 EUROPE 86
    • 8.3.1 GERMANY 90
    • 8.3.2 UK 91
    • 8.3.3 FRANCE 93
    • 8.3.4 REST OF EUROPE 94
  • 8.4 ASIA PACIFIC 96
    • 8.4.1 JAPAN 100
    • 8.4.2 CHINA 101
    • 8.4.3 INDIA 103
    • 8.4.4 REST OF ASIA PACIFIC (ROAPAC) 104
  • 8.5 REST OF THE WORLD 106
    • 8.5.1 LATIN AMERICA 110
    • 8.5.2 THE MIDDLE EAST 111
    • 8.5.3 AFRICA 113
      9 COMPETITIVE LANDSCAPE 115
  • 9.1 INTRODUCTION 115
  • 9.2 MARKET SHARE ANALYSIS, 2016 116
    • 9.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET: KEY PLAYERS 116
    • 9.2.2 EXTERNAL DEFIBRILLATORS MARKET: KEY PLAYERS 117
  • 9.3 COMPETITIVE SCENARIO 117
    • 9.3.1 KEY PRODUCT LAUNCHES AND APPROVALS (2015-2017) 118
    • 9.3.2 KEY AGREEMENTS, PARTNERSHIPS, CONTRACTS, AND COLLABORATIONS (2015-2017) 118
    • 9.3.3 KEY EXPANSIONS (2015-2017) 119
    • 9.3.4 KEY ACQUISITIONS, JOINT VENTURES, AND MERGERS (2015-2017) 119

10 COMPANY PROFILES 120
(Business Overview, Products & Services, Key Insights, Recent Developments, MnM View)*

  • 10.1 MEDTRONIC 120
  • 10.2 ST. JUDE MEDICAL 124
  • 10.3 BOSTON SCIENTIFIC 127
  • 10.4 PHILIPS 130
  • 10.5 ZOLL MEDICAL 133
  • 10.6 BIOTRONIK 136
  • 10.7 PHYSIO-CONTROL 138
  • 10.8 CARDIAC SCIENCE 141
  • 10.9 LIVANOVA 145
  • 10.10 NIHON KOHDEN 149
  • 10.11 SCHILLER 152
  • 10.12 MINDRAY MEDICAL 154
  • 10.13 MEDIANA 155
  • 10.14 METRAX 157
  • 10.15 METSIS MEDIKAL 158
*Details on Business Overview, Products & Services, Key Insights, Recent Developments, MnM View might not be captured in case of unlisted companies.
11 APPENDIX 159
  • 11.1 DISCUSSION GUIDE 159
  • 11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 164
  • 11.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 166
  • 11.4 AVAILABLE CUSTOMIZATIONS 168
  • 11.5 RELATED REPORTS 168
  • 11.6 AUTHOR DETAILS 169

LIST OF TABLES

TABLE 1 RECENT PRODUCT INNOVATIONS IN THE DEFIBRILLATORS MARKET 35
TABLE 2 DEFIBRILLATORS MARKET, BY REGION, 2015–2022 (USD MILLION) 47
TABLE 3 DEFIBRILLATORS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 48
TABLE 4 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION,
2015–2022 (USD MILLION) 49
TABLE 5 GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET, BY REGION, 2015–2022 (NO OF UNITS) 49
TABLE 6 NORTH AMERICAN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET,
BY COUNTRY (UNITS) 50
TABLE 7 EUROPEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET,
BY COUNTRY (UNITS) 50
TABLE 8 ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET,
BY COUNTRY (UNITS) 51
TABLE 9 ROW IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET, BY COUNTRY (UNITS) 51
TABLE 10 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE,
2015–2022 (USD MILLION) 51
TABLE 11 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY REGION, 2015–2022 (USD MILLION) 52
TABLE 12 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2015–2022 (USD MILLION) 53
TABLE 13 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2015–2022 (USD MILLION) 54
TABLE 14 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY REGION, 2015–2022 (USD MILLION) 55
TABLE 15 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY REGION, 2015–2022 (USD MILLION) 56
TABLE 16 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY REGION, 2015–2022 (USD MILLION) 57
TABLE 17 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2015–2022 (USD MILLION) 58
TABLE 18 GLOBAL EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2015–2022 (NO OF UNITS) 58
TABLE 19 NORTH AMERICAN EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY (UNITS) 58
TABLE 20 EUROPEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET, BY COUNTRY (UNITS) 59
TABLE 21 ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET,
BY COUNTRY (UNITS) 59
TABLE 22 ROW IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET,
BY COUNTRY (UNITS) 60
TABLE 23 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 60
TABLE 24 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2015–2022 (USD MILLION) 61
TABLE 25 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2015–2022 (USD MILLION) 61
TABLE 26 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2015–2022 (USD MILLION) 62
TABLE 27 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2015–2022 (USD MILLION) 63
TABLE 28 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2015–2022 (USD MILLION) 64
TABLE 29 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION,
2015–2022 (USD MILLION) 65
TABLE 30 DEFIBRILLATORS MARKET, BY END USER, 2015–2022 (USD MILLION) 67
TABLE 31 DEFIBRILLATORS MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS,
BY REGION, 2015–2022 (USD MILLION) 68
TABLE 32 DEFIBRILLATORS MARKET FOR PRE-HOSPITAL CARE SETTINGS, BY REGION, 2015–2022 (USD MILLION) 69
TABLE 33 DEFIBRILLATORS MARKET FOR PUBLIC ACCESS MARKETS, BY REGION,
2015–2022 (USD MILLION) 71
TABLE 34 DEFIBRILLATORS MARKET FOR HOME CARE SETTINGS, BY REGION,
2015–2022 (USD MILLION) 72
TABLE 35 DEFIBRILLATORS MARKET FOR ALTERNATE CARE MARKETS, BY REGION,
2015–2022 (USD MILLION) 73
TABLE 36 DEFIBRILLATORS MARKET, BY REGION, 2015–2022 (USD MILLION) 75
TABLE 37 DEFIBRILLATORS MARKET, BY REGION (UNITS) 75
TABLE 38 NORTH AMERICAN DEFIBRILLATORS MARKET, BY COUNTRY (UNITS) 76
TABLE 39 EUROPEAN DEFIBRILLATORS MARKET, BY COUNTRY (UNITS) 76
TABLE 40 ASIA-PACIFIC DEFIBRILLATORS MARKET, BY COUNTRY (UNITS) 77
TABLE 41 ROW DEFIBRILLATORS MARKET, BY COUNTRY (UNITS) 77
TABLE 42 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 80
TABLE 43 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 80
TABLE 44 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2015–2022 (USD MILLION) 80
TABLE 45 NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 81
TABLE 46 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2015–2022 (USD MILLION) 81
TABLE 47 NORTH AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 81
TABLE 48 NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER,
2015–2022 (USD MILLION) 82
TABLE 49 US: DEFIBRILLATORS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 83
TABLE 50 US: DEFIBRILLATORS MARKET, BY END USER, 2015–2022 (USD MILLION) 84
TABLE 51 CANADA: DEFIBRILLATORS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 85
TABLE 52 CANADA: DEFIBRILLATORS MARKET, BY END USER, 2015–2022 (USD MILLION) 85
TABLE 53 EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 88
TABLE 54 EUROPE: DEFIBRILLATORS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 88
TABLE 55 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2015–2022 (USD MILLION) 88
TABLE 56 EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 89
TABLE 57 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2015–2022 (USD MILLION) 89
TABLE 58 EUROPE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2015–2022 (USD MILLION) 89
TABLE 59 EUROPE: DEFIBRILLATORS MARKET, BY END USER, 2015–2022 (USD MILLION) 90
TABLE 60 GERMANY: DEFIBRILLATORS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 91
TABLE 61 GERMANY: DEFIBRILLATORS MARKET, BY END USER, 2015–2022 (USD MILLION) 91
TABLE 62 UK: DEFIBRILLATORS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 92
TABLE 63 UK: DEFIBRILLATORS MARKET, BY END USER, 2015–2022 (USD MILLION) 93
TABLE 64 FRANCE: DEFIBRILLATORS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 94
TABLE 65 FRANCE: DEFIBRILLATORS MARKET, BY END USER, 2015–2022 (USD MILLION) 94
TABLE 66 ROE: DEFIBRILLATORS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 95
TABLE 67 ROE: DEFIBRILLATORS MARKET, BY END USER, 2015–2022 (USD MILLION) 95
TABLE 68 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 98
TABLE 69 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 98
TABLE 70 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 98
TABLE 71 ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 99
TABLE 72 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2015–2022 (USD MILLION) 99
TABLE 73 ASIA PACIFIC: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2015–2022 (USD MILLION) 99
TABLE 74 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY END USER,
2015–2022 (USD MILLION) 100
TABLE 75 JAPAN: DEFIBRILLATORS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 101
TABLE 76 JAPAN: DEFIBRILLATORS MARKET, BY END USER, 2015–2022 (USD MILLION) 101
TABLE 77 CHINA: DEFIBRILLATORS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 102
TABLE 78 CHINA: DEFIBRILLATORS MARKET, BY END USER, 2015–2022 (USD MILLION) 103
TABLE 79 INDIA: DEFIBRILLATORS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 104
TABLE 80 INDIA: DEFIBRILLATORS MARKET, BY END USER, 2015–2022 (USD MILLION) 104
TABLE 81 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 105
TABLE 82 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY END USER,
2015–2022 (USD MILLION) 106
TABLE 83 ROW: DEFIBRILLATORS MARKET, BY REGION, 2015–2022 (USD MILLION) 108
TABLE 84 ROW: DEFIBRILLATORS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 108
TABLE 85 ROW: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE,
2015–2022 (USD MILLION) 108
TABLE 86 ROW: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2015–2022 (USD MILLION) 109
TABLE 87 ROW: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 109
TABLE 88 ROW: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2015–2022 (USD MILLION) 109
TABLE 89 ROW: DEFIBRILLATORS MARKET, BY END USER, 2015–2022 (USD MILLION) 110
TABLE 90 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 111
TABLE 91 LATIN AMERICA: DEFIBRILLATORS MARKET, BY END USER,
2015–2022 (USD MILLION) 111
TABLE 92 MIDDLE EAST: DEFIBRILLATORS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 112
TABLE 93 MIDDLE EAST: DEFIBRILLATORS MARKET, BY END USER,
2015–2022 (USD MILLION) 112
TABLE 94 AFRICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 113
TABLE 95 AFRICA: DEFIBRILLATORS MARKET, BY END USER, 2015–2022 (USD MILLION) 114


LIST OF FIGURES

FIGURE 1 MARKETS COVERED 16
FIGURE 2 RESEARCH DESIGN 19
FIGURE 3 DATA TRIANGULATION 25
FIGURE 4 DEFIBRILLATORS PRODUCT MARKET SNAPSHOT (2017 VS. 2022) 27
FIGURE 5 GLOBAL DEFIBRILLATORS MARKET, BY END USER (2017 VS. 2022) 28
FIGURE 6 DEFIBRILLATORS MARKET, BY REGION, 2017 29
FIGURE 7 TECHNOLOGICAL ADVANCEMENTS IN DEFIBRILLATORS AND GROWING FOCUS ON PROVIDING PUBLIC-ACCESS DEFIBRILLATORS ARE MAJOR FACTORS DRIVING MARKET GROWTH 31
FIGURE 8 CRT-DS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE DEFIBRILLATORS MARKET IN 2017 32
FIGURE 9 HOSPITALS, CLINICS, AND CARDIAC CENTERS WILL CONTINUE TO DOMINATE THE DEFIBRILLATORS MARKET BY 2022 33
FIGURE 10 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 33
FIGURE 11 DEFIBRILLATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 34
FIGURE 12 GERIATRIC POPULATION, BY REGION, 2015 – 2050 (MILLION) 36
FIGURE 13 RECENT PRODUCT RECALL BY FDA (US) OF MAJOR DEFIBRILLATOR
BRANDS (2016 -2018) 41
FIGURE 14 CRT-DS WILL CONTINUE TO DOMINATE THE DEFIBRILLATORS MARKET TILL 2022 47
FIGURE 15 NORTH AMERICA: DEFIBRILLATORS MARKET SNAPSHOT 79
FIGURE 16 EUROPE: DEFIBRILLATORS MARKET SNAPSHOT, 2017-2022 87
FIGURE 17 ASIA PACIFIC: DEFIBRILLATORS MARKET SNAPSHOT, 2017–2022 97
FIGURE 18 ROW: DEFIBRILLATORS MARKET SNAPSHOT, 2017–2022 107
FIGURE 19 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE DEFIBRILLATORS MARKET, 2014–2017 115
FIGURE 20 ICDS AND EXTERNAL DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2016 116
FIGURE 21 MEDTRONIC: COMPANY SNAPSHOT 120
FIGURE 22 ST. JUDE MEDICAL: COMPANY SNAPSHOT 124
FIGURE 23 BOSTON SCIENTIFIC: COMPANY SNAPSHOT 127
FIGURE 24 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 130
FIGURE 25 ASAHI KASEI: COMPANY SNAPSHOT 133
FIGURE 26 STRYKER: COMPANY SNAPSHOT 138
FIGURE 27 LIVANOVA: COMPANY SNAPSHOT 145
FIGURE 28 NIHON KOHDEN: COMPANY SNAPSHOT 149

Get in touch!

Looking for sample pages? Or want to speak to someone about discounts?

Please leave your details and we'll get back to you as soon as we can!